Now that we've reached Secret of the Mimic's endgame section, we're ready to begin playing through each of its three endings.

We know that the Mimic ultimately ends up in the Pizzaplex from Ruin, the DLC for FNAF: Security Breach, and that he is the ...

Sanofi announced that it will buy pharma company Blueprint Medicines for $129 per share, making the deal worth more than $9 billion. Blueprint specializes in systemic mastocytosis and other ...

We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where Blueprint Medicines Corporation (NASDAQ:BPMC) stands against other top ...

The Blueprint deal comes after Sanofi made an unsuccessful play in 2022 for another rare disease specialist, Horizon Therapeutics. In that case, Amgen took the prize with its $27.8 billion offer.

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...

Sanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to Pipeline The deal is Sanofi’s third acquisition so far this year, and executives signaled that more acquisitions could follow By ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

Sanofi is paying $129 per share in cash for Blueprint, amounting to a $9.1 billion equity value and a 27% premium on the biotech’s closing price on Friday.

NEW YORK — It was always going to be on defense. For the New York Knicks to stave off elimination, to get back in this Eastern Conference finals, they needed to somehow curb the Indiana Pacers ...

Claiming the new free blueprint in Black Ops 6 and Warzone is a quick and rewarding process. With just a few simple steps, you will unlock a fashionable and ready-to-use weapon setup that stands ...

Blueprint Medicines (NASDAQ:BPMC – Get Free Report) last issued its quarterly earnings results on Thursday, May 1st.The biotechnology company reported ($0.74) earnings per share for the quarter ...